Dana-Farber Research: High-Dose vitamin D3 does not provide benefit for metastatic colorectal cancer (IMAGE)

Dana-Farber Cancer Institute

Dana-Farber Research: High-Dose vitamin D3 does not provide benefit for metastatic colorectal cancer

Caption

A double-blind randomized phase 3 clinical trial led by Dana-Farber Cancer Institute researchers and conducted across several hundred cancer centers in the U.S. tested the addition of high-dose vitamin D3 to standard treatment for patients with untreated metastatic colorectal cancer.

Credit

Dana-Farber Cancer Institute

Usage Restrictions

Kindly courtesy Dana-Farber Cancer Institute

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.